← All companies
LFCR
Lifecore Biomedical, Inc.
$4.39
-0.03 -0.68%
Key statistics
from XBRL data in SEC filingsMarket cap
$165M
Revenue (TTM)
$129M
Net income (TTM)
-$38.7M
EPS (TTM)
$-1.27
P/E ratio
—
Dividend yield
—
Free cash flow
-$13.6M
Cash
$20.8M
Total assets
$225M
Gross margin
31.3%
52-week range
$3.63 – $8.98
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Regulation FD disclosure
Jul 2, 2026
8-K
Director or officer change; Shareholder vote results
Jun 5, 2026
10-Q
Quarter ended 2026-03-31
May 6, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 6, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 16, 2026
8-K
Item 5.08
Mar 5, 2026
8-K
Director or officer change
Jan 16, 2026
8-K
Regulation FD disclosure
Nov 17, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 6, 2025
8-K
Shareholder vote results
Oct 31, 2025
8-K
Director or officer change
Sep 26, 2025
8-K
Changed accountants
Aug 18, 2025
8-K
Regulation FD disclosure
Aug 12, 2025
10-K
Fiscal year ended 2025-05-25
Aug 7, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
8-K
Director or officer change
Jul 18, 2025
8-K
Director or officer change
Apr 16, 2025
8-K
Shareholder vote results
Apr 10, 2025
10-Q
Quarter ended 2025-02-23
Apr 3, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Apr 3, 2025
8-K
Other events
Jan 17, 2025
8-K
Regulation FD disclosure
Jan 7, 2025
10-Q
Quarter ended 2024-11-24
Jan 2, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 2, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Nov 26, 2024
8-K
Regulation FD disclosure
Nov 21, 2024
8-K
Shareholder vote results
Nov 8, 2024
10-Q
Quarter ended 2024-08-25
Oct 4, 2024
8-K
Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure
Oct 4, 2024
8-K
Director or officer change; Item 5.08
Sep 23, 2024
8-K
Other events
Sep 12, 2024
8-K
Unregistered sale of equity; Director or officer change; Regulation FD disclosure
Aug 29, 2024
8-K
Results of operations (earnings release)
Aug 26, 2024
10-K
Fiscal year ended 2024-05-26
Aug 26, 2024
8-K
Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results
Aug 21, 2024
10-Q
Quarter ended 2024-02-25
Aug 9, 2024
10-Q
Quarter ended 2023-11-26
Aug 9, 2024
10-Q
Quarter ended 2023-08-27
Aug 9, 2024
8-K
Director or officer change
Jul 24, 2024